Tag: bioavailable

April 17, 2018

Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, is pleased to announce positive topline results...
March 27, 2018

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

Biotechnology leader NanoSphere Health Sciences, LLC (CSE:NSHS) is pleased to announce the United States Patent and Trademark Office has granted...
March 19, 2018

What is Oncology Investing?

What is oncology investing? This sector can be intimidating for investors first getting into the space — here's a brief breakdown...
February 12, 2018

Clinical Study on Phivida’s Nano-CBD™ at the University of Nottingham (UK) in Collaboration with Artelo Biosciences, Inc.

Phivida Holdings Inc. ("Phivida" or the "Company") (CSE: VIDA) OTCMKTS: PHVAF) is pleased to report that Phivida Organics Inc., a...
April 11, 2017

Propanc Biopharma: Next Wave of Cancer Technology ?

The Investing News Network had the chance to speak with James Nathanielsz, CEO of Propanc Biopharma, about what the company...
March 8, 2017

Laguna Blends Launches its New Online Marketplace

Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) is proud to announce the launch of its highly anticipated new Online Marketplace. This exciting...
March 7, 2017

Protext Mobility Discusses Potential for Phytofare to treat Type II Diabetes

Protext Mobility (OTC PINK:TXTM) discusses the potential of its main product Phytofare in treating type II Diabetes.